Scinovex
reviewTop 1% cited

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis

JNCI Journal of the National Cancer Institute · 2014 · Vol. 106(6) · pp. dju124–dju124
Arnoud J. TempletonMairéad G. McNamaraBoštjan ŠerugaFrancisco Vera-BadilloPriya AnejaAlberto OcañaRaya Leibowitz‐AmitGuru SonpavdeJennifer J. KnoxBen TranIan F. TannockEitan Amir

Abstract

A high NLR is associated with an adverse OS in many solid tumors. The NLR is a readily available and inexpensive biomarker, and its addition to established prognostic scores for clinical decision making warrants further investigation.

Inflammatory Biomarkers in Disease PrognosisCancer, Lipids, and MetabolismPancreatic and Hepatic Oncology ResearchHazard ratioMedicineInternal medicineMeta-analysisNeutrophil to lymphocyte ratioOncologyConfidence intervalBiomarkerCutoffLymphocyte

MeSH terms

HumansLymphocytesNeoplasmsNeutrophilsPredictive Value of TestsPrognosisSensitivity and SpecificitySurvival RateOdds RatioTreatment OutcomeDisease-Free SurvivalLymphocyte Count
Citations
3,162
FWCI
71.88
field-weighted impact
References
142
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.